A finished report, not a chat answer.
Deep research on any question, due diligence on any public company, a 13F breakdown of any fund, a graded audit of any domain. Built from live data, research and filing reports cited to their sources, delivered in one to three minutes, the deepest up to five. Nothing to sign up for, nothing recurring. Pay by card at checkout and the report is yours. Agents skip the card and pay per call over x402 or MPP.
Need it again when something changes? A monitor watches one target and re-runs the report when the facts move. $5 a month, cancel anytime.
See monitors →- Domain security audit: github.com →
- Company due-diligence dossier: NVDA →
- SEC filing report: AAPL →
- Fund portfolio report (13F): Berkshire Hathaway →
- Insider flow report (Form 4): NVDA →
- LinkedIn article, ready to publish: Why software will be bought per request, not per seat →
- Market / competitor brief: Electric vehicle fast-charging networks in the United States →
- FDA recall report: losartan →
- Deep research report: Which US airlines are most exposed to jet fuel price spikes in 2026, and how are they hedged? →
- Ticker pack: dossier, insider flow and holders: MSFT →
- Solana token due-diligence brief: JUPyiw…DvCN →
Every report you can buy
Card prices include payment processing. An agent paying per call over x402 or MPP pays the tool's own price instead. Both buy the same report.
Ask a hard question
Multiple live web searches, ranked sources, a cited report on whatever you ask.
Everything on a public company
SEC filings, insider filings, financials and red flags, each one cited to the filing it came from.
What did they just file
The company's newest SEC filings, with the document itself read and explained in plain language, cited to the filing.
One ticker, the whole picture
Company dossier, recent SEC filings, insider buying and selling, and its 5%+ holders from Schedule 13D/13G, in one cited report.
Is this Solana token safe to touch
Mint and freeze authority, LP lock, holder concentration, liquidity and every named risk flag, graded and cited from on-chain sources.
Follow the smart money
What a fund holds, and what it bought, added, trimmed and exited last quarter, from SEC 13F filings, cited.
Who's buying, who's selling
The newest Form 4 filings against a company (up to 100, last 90 days) with the actual transactions parsed: open-market buys and sales by insider, awards and exercises set apart, a grounded signal read. SEC EDGAR, cited.
Who's in the market, and how they differ
Market at a glance, the key players and pricing, recent moves, differentiation, risks and a bottom line. Live web research with citations, nothing from memory.
A publish-ready LinkedIn article, with the images
Grounded research with cited sources, three headline options, a hook-first body with facts linked to their sources, key takeaways, a companion post with hashtags, and generated images at LinkedIn's own sizes: cover 1920x1080, link-share 1200x627, feed square and portrait. Paste and publish.
Is it recalled?
The newest FDA drug, food and device recall records for a product, brand or ingredient (up to 20 per feed): firm, class, reason, status, distribution. Organized and explained, cited to the FDA feeds.
Is your domain secure?
SPF, DMARC, DKIM, TLS and security headers, one graded report with the exact fixes. Why your mail hits spam, answered.
One-time charge · card · no subscription, no auto-renew · agents buy the same reports over x402 / MPP in USDC · want it re-run on change? Monitors
Free SEC filing pages, no card needed: insider filings by ticker · 13F holdings by fund · company profiles by ticker